UTHR logo

United Therapeutics (UTHR) Non Current Assets

UTHR Annual Non Current Assets

$3.62 B
+$951.80 M+35.73%

31 December 2023

UTHR Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

UTHR Quarterly Non Current Assets

$3.12 B
+$19.00 M+0.61%

30 September 2024

UTHR Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

UTHR Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.7%-12.4%
3 y3 years+47.7%-12.4%
5 y5 years+121.4%+43.3%

UTHR Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+35.7%-13.6%+17.2%
5 y5-yearat high+76.5%-13.6%+52.4%
alltimeall timeat high>+9999.0%-13.6%>+9999.0%

United Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$3.12 B(+0.6%)
June 2024
-
$3.10 B(-4.4%)
Mar 2024
-
$3.25 B(-10.2%)
Dec 2023
$3.55 B(+5.0%)
$3.62 B(+1.4%)
Sept 2023
-
$3.56 B(+2.8%)
June 2023
-
$3.47 B(+10.0%)
Mar 2023
-
$3.15 B(+18.3%)
Dec 2022
$3.38 B(+45.5%)
$2.66 B(-2.2%)
Sept 2022
-
$2.73 B(-4.7%)
June 2022
-
$2.86 B(+3.1%)
Mar 2022
-
$2.77 B(-2.5%)
Dec 2021
$2.32 B(+7.2%)
$2.85 B(+6.9%)
Sept 2021
-
$2.66 B(+5.4%)
June 2021
-
$2.53 B(-3.8%)
Mar 2021
-
$2.63 B(+7.3%)
Dec 2020
$2.17 B(+16.2%)
$2.45 B(-3.7%)
Sept 2020
-
$2.54 B(+9.4%)
June 2020
-
$2.33 B(+6.7%)
Mar 2020
-
$2.18 B(+6.4%)
Dec 2019
$1.86 B(+5.5%)
$2.05 B(-0.8%)
Sept 2019
-
$2.07 B(+17.5%)
June 2019
-
$1.76 B(-1.4%)
Mar 2019
-
$1.78 B(+9.3%)
Dec 2018
$1.77 B(+22.1%)
$1.63 B(-9.4%)
Sept 2018
-
$1.80 B(+11.3%)
June 2018
-
$1.62 B(+16.9%)
Mar 2018
-
$1.39 B(-3.1%)
Dec 2017
$1.45 B(+1.6%)
$1.43 B(+10.4%)
Sept 2017
-
$1.30 B(+15.0%)
June 2017
-
$1.13 B(+6.7%)
Mar 2017
-
$1.06 B(+17.4%)
Dec 2016
$1.42 B(+11.7%)
$900.80 M(+2.0%)
Sept 2016
-
$883.20 M(-0.3%)
June 2016
-
$886.10 M(-0.7%)
Mar 2016
-
$892.50 M(-1.8%)
Dec 2015
$1.28 B(+33.2%)
$909.10 M(-2.3%)
Sept 2015
-
$930.71 M(+2.5%)
June 2015
-
$907.78 M(+0.8%)
Mar 2015
-
$900.52 M(-2.8%)
Dec 2014
$957.59 M(+4.7%)
$926.82 M(-6.7%)
Sept 2014
-
$993.57 M(-7.3%)
June 2014
-
$1.07 B(-4.7%)
Mar 2014
-
$1.12 B(-4.1%)
Dec 2013
$914.38 M(+36.8%)
$1.17 B(+17.9%)
Sept 2013
-
$994.91 M(+13.8%)
June 2013
-
$874.09 M(+2.5%)
Mar 2013
-
$852.79 M(-11.0%)
Dec 2012
$668.47 M(+18.8%)
$958.13 M(+3.1%)
Sept 2012
-
$929.31 M(-5.7%)
June 2012
-
$985.79 M(-0.2%)
Mar 2012
-
$987.52 M(+3.3%)
Dec 2011
$562.46 M
$955.62 M(+16.4%)
DateAnnualQuarterly
Sept 2011
-
$820.92 M(+17.1%)
June 2011
-
$701.23 M(+4.0%)
Mar 2011
-
$674.56 M(+1.1%)
Dec 2010
$764.49 M(+135.6%)
$667.15 M(-2.5%)
Sept 2010
-
$684.30 M(+1.9%)
June 2010
-
$671.38 M(-7.8%)
Mar 2010
-
$727.96 M(+0.1%)
Dec 2009
$324.51 M(+9.1%)
$727.04 M(+6.5%)
Sept 2009
-
$682.58 M(+2.8%)
June 2009
-
$663.79 M(+4.5%)
Mar 2009
-
$635.45 M(+10.1%)
Dec 2008
$297.45 M(-15.6%)
$577.09 M(+22.6%)
Sept 2008
-
$470.76 M(+18.5%)
June 2008
-
$397.18 M(+28.0%)
Mar 2008
-
$310.20 M(+32.3%)
Dec 2007
$352.46 M(+27.1%)
$234.56 M(+3.9%)
Sept 2007
-
$225.84 M(+0.4%)
June 2007
-
$224.96 M(+3.5%)
Mar 2007
-
$217.34 M(+8.9%)
Dec 2006
$277.37 M(+66.3%)
$199.60 M(+69.8%)
Sept 2006
-
$117.58 M(-0.5%)
June 2006
-
$118.17 M(+0.1%)
Mar 2006
-
$118.08 M(-5.3%)
Dec 2005
$166.76 M(+50.9%)
$124.66 M(+13.0%)
Sept 2005
-
$110.28 M(+2.5%)
June 2005
-
$107.59 M(+10.2%)
Mar 2005
-
$97.62 M(+1.0%)
Dec 2004
$110.49 M(+23.2%)
$96.67 M(+10.9%)
Sept 2004
-
$87.15 M(-0.8%)
June 2004
-
$87.86 M(+0.1%)
Mar 2004
-
$87.75 M(-2.3%)
Dec 2003
$89.72 M(-36.8%)
$89.78 M(+8.5%)
Sept 2003
-
$82.76 M(+12.6%)
June 2003
-
$73.47 M(+2.3%)
Mar 2003
-
$71.78 M(+68.1%)
Dec 2002
$141.86 M(+105.6%)
$42.71 M(+32.2%)
Sept 2002
-
$32.32 M(+4.6%)
June 2002
-
$30.91 M(-75.2%)
Mar 2002
-
$124.84 M(-12.8%)
Dec 2001
$69.00 M(-68.9%)
$143.12 M(+28.9%)
Sept 2001
-
$111.05 M(+92.4%)
June 2001
-
$57.72 M(+33.5%)
Mar 2001
-
$43.24 M(+51.6%)
Dec 2000
$222.12 M(+321.5%)
$28.52 M(+145.8%)
Sept 2000
-
$11.61 M(-1.4%)
June 2000
-
$11.78 M(-1.1%)
Mar 2000
-
$11.90 M(+65.3%)
Dec 1999
$52.70 M(+213.7%)
$7.20 M(+94.6%)
Sept 1999
-
$3.70 M(+76.2%)
June 1999
-
$2.10 M(-8.7%)
Mar 1999
-
$2.30 M
Dec 1998
$16.80 M
-

FAQ

  • What is United Therapeutics annual long term assets?
  • What is the all time high annual non current assets for United Therapeutics?
  • What is United Therapeutics annual non current assets year-on-year change?
  • What is United Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for United Therapeutics?
  • What is United Therapeutics quarterly non current assets year-on-year change?

What is United Therapeutics annual long term assets?

The current annual non current assets of UTHR is $3.62 B

What is the all time high annual non current assets for United Therapeutics?

United Therapeutics all-time high annual long term assets is $3.62 B

What is United Therapeutics annual non current assets year-on-year change?

Over the past year, UTHR annual long term assets has changed by +$951.80 M (+35.73%)

What is United Therapeutics quarterly long term assets?

The current quarterly non current assets of UTHR is $3.12 B

What is the all time high quarterly non current assets for United Therapeutics?

United Therapeutics all-time high quarterly long term assets is $3.62 B

What is United Therapeutics quarterly non current assets year-on-year change?

Over the past year, UTHR quarterly long term assets has changed by -$442.00 M (-12.40%)